Non-Hodgkin Lymphoma Archives - Page 9 of 11 - Oncology Nurse Advisor

Non-Hodgkin Lymphoma

Idelalisib promising for indolent non-Hodgkin lymphomas

The new drug idelalisib appears to offer hope for fighting slow-growing , or indolent, non-Hodgkin lymphomas (iNHLs). These lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming increasingly resistant to therapy over time. The phase 2 study involved 125 patients aged 33 to 87 years with indolent non-Hodgkin lymphoma (iNHL)…


This slideshow reviews vincristine, indicated for Hodgkin disease, Kaposi sarcoma, leukemia, neuroblastoma, non-Hodgkin lymphoma, rhabdomyosarcoma, and Wilms’ tumor.

Bendamustine (Treanda)

This slideshow examines bendamustine (Treanda), indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL).

Next post in Web Exclusives